News For The Inventor In All Of US

For millions of people with diabetes, daily finger pricking with needles in order to get a measurement of their blood glucose is an accepted, but unpleasant, part of their lifestyles. Though physicists have been trying to come up with laser beam technology that effectively substitutes for the needle, the accomplishment has evaded them for the past 20 years.  Now, physicists at the University of Toronto (UT) have found a way to get around the most prickly problem with using a laser beam....

Afinitor®, the Novartis trademark for the cancer fighter, everolimus, is used for the treatment of advanced renal cell carcinoma (RCC), inoperable cases of certain pancreatic cancers, and to aid successful acceptance of transplants.  Now, the results of a Phase III study of Afinitor administered to women with advanced breast cancer have been announced, and the words used to describe the drug are "game changer."

There is nothing more discouraging in human discourse than someone yawning in your face while you're speaking to him.  "Oh, excuse me," he might say, "I guess I'm just very tired."  (Yeah, sure!)

But now, scientists have evidence that your listener may not be bored at all; but just chilling... his brain.  

Arthritis is a joint disease that results in a progressive loss of cartilage, just as osteoporosis results in progressive loss of bone.  Though osteoporosis drugs are intended to regenerate bone growth, to date, arthritis drugs can only reduce inflammation and, thereby, reduce pain.  But observation of patients taking a certain osteoporosis drug, by researchers at the University of Rochester Medical Center (URMC), led to the recent finding that this drug not only restored bone but cartilage as well.